Streetbeat News

Partnerships

AMD

AMD (NASDAQ:AMD) has partnered with Optiver, a global market maker, to modernize its data center infrastructure. Optiver is utilizing AMD's high-performance computing products, including 4th Gen AMD EPYC processors, Solarflare Ethernet Adapters, Virtex UltraScale+ FPGAs, and Alveo Accelerators, to enhance its financial market operations. This collaboration aims to address technical challenges in capital markets by building advanced systems for better efficiency and speed, demonstrating AMD's capability to meet commercial customer needs with its diverse compute engine portfolio.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 1:08 pm

RSI

Infront has announced a partnership with Rush Street Interactive (RSI) to expand its betting operations in North America. This strategic collaboration aims to leverage Infront's expertise in sports marketing and RSI's established online gaming and betting platform to capture a larger share of the growing North American betting market.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 1:06 pm

LIQT

LiqTech International, Inc. (NASDAQ:LIQT) and Dan Marine Group (DMG) have entered into a partnership to expand LiqTech's marine water treatment solutions in the Chinese shipbuilding and repair market. This includes marine scrubber water treatment solutions and new exhaust gas recirculation (EGR) water treatment systems for dual fuel marine vessels. DMG will also service existing LiqTech marine installations. LiqTech's technology, which has been installed on over 170 large commercial ships since 2017, aims to reduce pollution and enhance fuel savings for ship owners.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 1:04 pm

TTOO

T2 Biosystems, a leader in the development of innovative medical diagnostic products, has announced a Letter of Intent (LOI) for a partnership aimed at advancing the diagnosis and treatment of Lyme disease. This strategic move could significantly enhance T2 Biosystems' position in the medical diagnostics market, particularly in the area of infectious diseases.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 1:02 pm

ANSS

SDGR

Ansys (ANSS) and Schrödinger (SDGR) have announced a collaboration to develop an Integrated Computational Materials Engineering (ICME) approach. This partnership aims to enhance the development of advanced materials by leveraging both companies' strengths in simulation and computational science.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 1:01 pm

ETN

Eaton (ETN) is collaborating with Endurant Energy to deploy 10 battery storage projects in New York City, valued at over $7M. These projects, with a combined capacity of over 150 MWh, aim to support clean, reliable power and strengthen the electric grid in the Bronx and Staten Island by providing load relief during peak demand hours and helping the local utility meet growing electricity demands without major substation upgrades. Eaton will contribute its expertise, technologies, and equipment, including switchgear, switchboards, and transformers, to ensure safe grid interconnection.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:51 pm

ICCM

IceCure Medical (ICCM) is anticipated to receive a total of $13.2M from Terumo during the initial term, including $4M already received, $8.2M upon order completion, and $1M for milestone-based payments.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:45 pm

ICCM

An independent study in Japan showed 0% breast cancer local recurrence 5 years after treatment with IceCure's ProSense, demonstrating its potential as a standard treatment for early-stage breast cancer. The study, published in Breast Cancer journal, highlighted excellent cosmetic outcomes, high patient satisfaction, and improved quality of life post-cryoablation. IceCure's distribution partner in Japan, Terumo Corporation, plans to submit a regulatory clearance application for ProSense in H2 2024. IceCure expects to receive a total of $13.2 million from Terumo for exclusive distribution rights in Japan.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:45 pm

DTIL

Precision BioSciences, Inc. (NASDAQ:DTIL) announced its partner iECURE received FDA Fast Track designation for ECUR-506, a gene insertion program for treating neonatal onset Ornithine Transcarbamylase (OTC) deficiency. This designation, which aims to expedite the development and review of treatments for serious conditions, highlights the potential of Precision's ARCUS platform. ECUR-506, utilizing a PCSK9-specific ARCUS nuclease licensed from Precision, has also received Rare Pediatric Disease and Orphan Drug designations from the FDA, and Orphan designation from the European Commission. The OTC-HOPE study, a Phase 1/2 trial, is currently enrolling in the UK, with sites in the US and Australia activating later this year.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:37 pm

SIDU

Sidus Space announced its role as a teammate on the NASA Lunar Terrain Vehicle Services contract, marking a significant milestone for the company in its involvement with space exploration and services.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:31 pm